. .

( )

. . , ,
. . 1, ,
. . ,
. . ,
. . . ,

() . , . , , (Canadian Pediatric Ichemic Stroke Pegistry) 2,7 100 000 , 2530% 50% [1]. . . . [2] . 2,14 100 000 , 6,94 100 000, 1 4000 , 45 . 0,6 100 000 [2].

: 312% , 6174% . 842% [1, 3].

, ( , -, .), (), , , . [2, 4].

, , (), 23 , 17 [5, 6]. , : , , - , , , , , , , , , , [7, 8]. , , () [9, 10]. , (), () β₂--1 (-β₂-1) (), / / . , , , .

, . , , , , . / , , , , [2, 11]. , .

, . , 1999 . (American College of Rheumatology, ACR), 12 7 . , , , [12]. , , , , , , . .

.

., 7 , . . . 2014 . , . . .

2013 ., , , , - . , , .

2014 . , 39,8 C, . , , , 4052 /, ( 3,8 × 10⁹/), ( 92 /). , . ( , ) .

2014 . - ( 5 ). - : , .

, -β2--I, > 200 /, () 1:1280, ( 2,8 × 10⁹/), ( 76 /) , 52 /. - : , , 3- , , , , , , . ? 1 // (30 /), - / 250 / 2, 2,5 / ( 1,71,9). 600 / (23 //). . : , , , . 20 /, .

. 2014 . . . : , , , , , . - () , , , , . : , , , , , , . : , , , , . . . ( ): , . , - (. 1 2).

: 24 / ( 020 /), ., : -IgG 15 / ( 07), -Ig 24 / ( 010), .

, - , , - , , , -β₂- I . .

. (MTHFR Ala 222Val CT) I (PAI-I (SERPINE) 675 5G/4G).

, , . . ( / 0,3 /). , (, , , , , ).

4 . . , , . - , . . : , , , . , . : , , , , , . : , . . .

- . , , .

10 / (0,3 //), ( 1,81,9).

, . .

, - , , - . ( ). , , . , .

1. DeVeber G. Canadian Pediatric Ichemic Stroke Pegistry // Paediatr Child Health. 2000: A17.
2. . ., . ., . ., . ., . . . . ., 2011. 72 .
3. Fox C. K., Fullerton H. J. Recent Advances in Childhood Arterial Ischemic Stroke // Curr Atheroscler Rep. 2010, 112, 217224.
4. Poisson S. N., Schardt T. Q., DIngman A., Bernard T. J. Etiology and treatment of arterial ischemic stroke in children and young adults // Curr Treat Options Neurol. 2014, 16 (10), 315.
5. Holmqvist M., Simard J. F., Asplund K., Arkema E. V. Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies // RMD Open. 2015, 16; 1 (1): e000168.
6. Wang I. K., Muo C. H., Chang Y. C., Liang C. C., Lin S. Y., Chang C. T., Yen T. H., Chuang F. R., Chen P. C., Huang C. C., Sung F. C. Risks, subtypes, and hospitalization costs of stroke among patients with systemic lupus erythematosus: a retrospective cohort study in Taiwan // J Rheumatol. 2012; 39 (8): 16111618.
7. Fernández-Nebro A., Rúa-Figueroa Í., López-Longo F. J., Galindo-Izquierdo M., Calvo-Alén J., Olivé-Marqués A., Ordóñez-Cañizares C., Martín-Martínez M. A., Blanco R., Melero-González R., Ibáñez-Rúan J., Bernal-Vidal J. A., Tomero-Muriel E., Uriarte-Isacelaya E., Horcada-Rubio L., Freire-González M., Narváez J., Boteanu A. L., Santos-Soler G., Andreu J. L., Pego-Reigosa J. M. EAS-SER (Systemic Diseases Study Group of Spanish Society of Rheumatology). Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry // Medicine (Baltimore). 2015; 94 (29): e1183.
8. Ballocca F., DAscenzo F., Moretti C., Omedè P., Cerrato E., Barbero U., Abbate A., Bertero M. T., Zoccai G. B., Gaita F. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis // Eur J Prev Cardiol. 2015, 22 (11): 14351441.
9. Yu H. H., Lee J. H., Wang L. C., Yang Y. H., Chiang B. L. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study // Lupus. 2006; 15 (10): 651657.
10. Hawro T., Bogucki A., Krupiska-Kun M., Maurer M., Woniacka A. Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2 GPI antibodies in patients with systemic lupus erythematosus // PLoS One. 2015, 17; 10 (3): e0119911.
11. Mallick A. A., Ganesan V., Kirkham F. J., Fallon P., Hedderly T., McShane T., Parker A. P., Wassmer E., Wraige E., Amin S., Edwards H. B., Tilling K., OCallaghan F. J. Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study // Lancet Neurol. 2014; 13 (1): 3543.
12. Böckle B. C., Jara D., Aichhorn K., Junker D., Berger T., Ratzinger G., Sepp N. T. Cerebral large vessel vasculitis in systemic lupus erythematosus // Lupus. 2014; 23 (13): 14171421.